Prevalence and predictors of return visits to pediatric emergency departments

Ayobami T Akenroye1, Cary W Thurm, Mark I Neuman

  • 1Division of Emergency Medicine, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts.

Insights

Pediatric emergency department (ED) revisits occur in 3.3% of discharged patients, with higher rates for those with chronic conditions or high severity. Understanding these factors can help reduce avoidable ED use.

Area of Science:

  • Pediatric Emergency Medicine
  • Health Services Research
  • Epidemiology

Background:

  • Pediatric emergency departments (EDs) manage a significant volume of patient visits.
  • Understanding return visit patterns is crucial for optimizing healthcare resource allocation and patient care.
  • Identifying factors associated with revisits can inform targeted interventions.

Purpose of the Study:

  • To determine the rate of return visits to pediatric EDs within 72 hours of discharge.
  • To identify patient- and visit-level factors associated with these return visits.
  • To identify factors associated with hospitalization upon return to the ED.

Main Methods:

  • Retrospective cohort study utilizing data from the Pediatric Health Information System (PHIS) in 2012.
  • Included patients under 18 years old discharged from 23 pediatric EDs.
  • Primary outcomes were return visits within 72 hours and hospitalizations during these return visits.

Main Results:

  • 3.3% of discharged pediatric ED patients (47,294/1,415,721) had a return visit within 72 hours.
  • Of those returning, 19.7% (9,295) were hospitalized.
  • Factors associated with increased return visits included chronic conditions, higher severity scores, and age under 1 year. Higher severity, chronic conditions, younger age, overnight arrival, and private insurance were associated with hospitalization on return.

Conclusions:

  • Patient and visit characteristics significantly influence the likelihood of pediatric ED revisits and subsequent hospitalizations.
  • Specific patient groups, such as those with sickle cell disease (10.7%) and cancer (7.3%), exhibit particularly high revisit rates.
  • These findings can guide strategies to optimize care and reduce unnecessary ED utilization.
Abstract

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
2.3K
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable...
78
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
918
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
729
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
532